Amneal Pharmaceuticals, Inc. (AMRX) Q3 2023 Earnings Results

Amneal Pharmaceuticals Beats on EPS, Stock Up 2.38%

Amneal Pharmaceuticals reported a strong earnings surprise with an EPS of $0.19, significantly beating expectations. The stock reacted positively, rising 2.38% following the announcement. However, without revenue figures or further guidance, investors may be cautious about the company's overall performance and future outlook.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.19	N/A	+95.88%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

Amneal Pharmaceuticals Beats on EPS, Stock Up 2.38%

Key numbers

Management commentary

Amneal Pharmaceuticals, Inc.

More earnings this week

Amneal Pharmaceuticals Beats on EPS, Stock Up 2.38%

Key numbers

Management commentary